Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for SENS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 52.86M
March 31, 2026 41.80M
December 31, 2025 41.27M
September 30, 2025 40.81M
June 30, 2025 40.73M
March 31, 2025 654.22M
December 31, 2024 595.35M
September 30, 2024 545.61M
June 30, 2024 535.28M
March 31, 2024 530.82M
December 31, 2023 530.36M
September 30, 2023 528.18M
June 30, 2023 492.83M
March 31, 2023 479.78M
December 31, 2022 479.64M
September 30, 2022 478.21M
June 30, 2022 465.33M
March 31, 2022 463.23M
December 31, 2021 447.28M
September 30, 2021 445.62M
June 30, 2021 445.12M
March 31, 2021 427.92M
December 31, 2020 265.58M
Date Value
September 30, 2020 244.24M
June 30, 2020 230.55M
March 31, 2020 204.44M
December 31, 2019 203.45M
September 30, 2019 203.37M
June 30, 2019 177.03M
March 31, 2019 176.96M
December 31, 2018 176.92M
September 30, 2018 176.73M
June 30, 2018 8.795M
March 31, 2018 137.24M
December 31, 2017 136.88M
September 30, 2017 136.69M
June 30, 2017 123.19M
March 31, 2017 94.10M
December 31, 2016 93.57M
September 30, 2016 93.39M
June 30, 2016 93.37M
March 31, 2016 91.56M
December 31, 2015 75.76M
September 30, 2015 1.656B
December 31, 2014 138.00M
September 30, 2014 120.00M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Electromed, Inc. 8.366M
Tandem Diabetes Care, Inc. 69.54M
Accuray, Inc. 119.43M
Micron Solutions, Inc. --
Orthofix Medical, Inc. 40.73M